Skip Nav Destination
Issues
15 October 2021
-
Cover Image
Cover Image
The cover shows a colorized second-generation harmonics microscopy image highlighting the collagen fibers present in the extracellular matrix of a section of normal breast tissue. For details, see the article by Thompson and colleagues on page 5660 of this issue. - PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkEditorial Board
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
CCR Drug Updates
FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With RET Gene Mutations or Fusions
Janice Kim; Diana Bradford; Erin Larkins; Lee H. Pai-Scherf; Somak Chatterjee; Pallavi S. Mishra-Kalyani; Emily Wearne; Whitney S. Helms; Amal Ayyoub; Youwei Bi; Jielin Sun; Rosane Charlab; Jiang Liu; Hong Zhao; Dun Liang; Soma Ghosh; Reena Philip; Richard Pazdur; Marc R. Theoret; Julia A. Beaver; Harpreet Singh
Review
Perspectives
Special Report
A Grant-Based Experiment to Train Clinical Investigators: The AACR/ASCO Methods in Clinical Cancer Research Workshop
Daniel D. Von Hoff; Gary M. Clark; Charles A. Coltman; Mary L. Disis; S.G. Eckhardt; Lee M. Ellis; Margaret Foti; Elizabeth Garrett-Mayer; Mithat Gönen; Manuel Hidalgo; Susan G. Hilsenbeck; John H. Littlefield; Patricia M. LoRusso; H. Kim Lyerly; Neal J. Meropol; Jyoti D. Patel; Steven Piantadosi; Dean A. Post; Meredith M. Regan; Yu Shyr; Margaret A. Tempero; Joel E. Tepper; Jamie Von Roenn; Louis M. Weiner; Donn C. Young; Nu V. Vu
Clinical Trials: Targeted Therapy
Niraparib for Advanced Breast Cancer with Germline BRCA1 and BRCA2 Mutations: the EORTC 1307-BCG/BIG5–13/TESARO PR-30–50–10-C BRAVO Study
Nicholas C. Turner; Judith Balmaña; Coralie Poncet; Theodora Goulioti; Konstantinos Tryfonidis; Aafke H. Honkoop; Gabriele Zoppoli; Evangelia Razis; Oskar T. Johannsson; Marco Colleoni; Andrew N. Tutt; William Audeh; Michail Ignatiadis; Audrey Mailliez; Olivier Trédan; Antonino Musolino; Peter Vuylsteke; Maria Jose Juan-Fita; Iain R.J. Macpherson; Bella Kaufman; Luis Manso; Lori J. Goldstein; Susan L. Ellard; István Láng; Kai Yu Jen; Virginie Adam; Saskia Litière; John Erban; David A. Cameron; on behalf of the BRAVO Steering Committee and the BRAVO investigators
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia
Gang An; Daobin Zhou; Shu Cheng; Keshu Zhou; Jianyong Li; Jianfeng Zhou; Liping Xie; Jie Jin; Liye Zhong; Lingzhi Yan; Haiyi Guo; Chenmu Du; Jinhua Zhong; Yiling Yu; Binghao Wu; Lugui Qiu
A Randomized, Phase III Study of Lenvatinib in Chinese Patients with Radioiodine-Refractory Differentiated Thyroid Cancer
Xiangqian Zheng; Zhengang Xu; Qinghai Ji; Minghua Ge; Feng Shi; Jianwu Qin; Feng Wang; Guang Chen; Yuan Zhang; Rui Huang; Jian Tan; Tao Huang; Sijin Li; Zhongwei Lv; Yansong Lin; Zhuming Guo; Tomoki Kubota; Takuya Suzuki; Hiroki Ikezawa; Ming Gao
Clinical Trials: Immunotherapy
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors
Corey C. Foster; Gini F. Fleming; Theodore G. Karrison; Chih-Yi Liao; Ami V. Desai; John W. Moroney; Mark J. Ratain; Rita Nanda; Blase N. Polite; Olwen M. Hahn; Peter H. O'Donnell; Everett E. Vokes; Hedy L. Kindler; Robyn Hseu; Linda A. Janisch; Julia Dai; Mark D. Hoffman; Ralph R. Weichselbaum; Sean P. Pitroda; Steven J. Chmura; Jason J. Luke
A Phase I Study of the Combination of Pexidartinib and Sirolimus to Target Tumor-Associated Macrophages in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
Gulam A. Manji; Brian A. Van Tine; Shing M. Lee; Alexander G. Raufi; Ilenia Pellicciotta; Angela C. Hirbe; Jaya Pradhan; Andrew Chen; Raul Rabadan; Gary K. Schwartz
GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study
Premal H. Thaker; William H. Bradley; Charles A. Leath, III; Camille Gunderson Jackson; Nicholas Borys; Khursheed Anwer; Lauren Musso; Junko Matsuzaki; Wiam Bshara; Kunle Odunsi; Ronald D. Alvarez
Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
Jacek Hajda; Barbara Leuchs; Assia L. Angelova; Veronika Frehtman; Jean Rommelaere; Mieke Mertens; Maximilian Pilz; Meinhard Kieser; Ottheinz Krebs; Michael Dahm; Bernard Huber; Christine E. Engeland; Athanasios Mavratzas; Nicolas Hohmann; Jutta Schreiber; Dirk Jäger; Niels Halama; Oliver Sedlaczek; Matthias M. Gaida; Volker Daniel; Christoph Springfeld; Guy Ungerechts
Precision Medicine and Imaging
TP53 Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia
Riccardo Bomben; Francesca Maria Rossi; Filippo Vit; Tamara Bittolo; Tiziana D'Agaro; Antonella Zucchetto; Erika Tissino; Federico Pozzo; Elena Vendramini; Massimo Degan; Eva Zaina; Ilaria Cattarossi; Paola Varaschin; Paola Nanni; Michele Berton; Alessandra Braida; Jerry Polesel; Jared A. Cohen; Enrico Santinelli; Annalisa Biagi; Massimo Gentile; Fortunato Morabito; Gilberto Fronza; Gabriele Pozzato; Giovanni D'Arena; Jacopo Olivieri; Pietro Bulian; Chris Pepper; Anna Hockaday; Anna Schuh; Peter Hillmen; Davide Rossi; Annalisa Chiarenza; Francesco Zaja; Francesco Di Raimondo; Giovanni Del Poeta; Valter Gattei
Improving Risk Stratification for Pediatric Patients with Rhabdomyosarcoma by Molecular Detection of Disseminated Disease
Nathalie S.M. Lak; Timon L. Voormanns; Lily Zappeij-Kannegieter; Lieke M.J. van Zogchel; Marta Fiocco; Max M. van Noesel; Johannes H.M. Merks; C. Ellen van der Schoot; Godelieve A.M. Tytgat; Janine Stutterheim
Author Choice
Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer
Aparna R. Parikh; Emily E. Van Seventer; Giulia Siravegna; Anna V. Hartwig; Ariel Jaimovich; Yupeng He; Katie Kanter; Madeleine G. Fish; Kathryn D. Fosbenner; Benchun Miao; Susannah Phillips; John H. Carmichael; Nihaarika Sharma; Joy Jarnagin; Islam Baiev; Yojan S. Shah; Isobel J. Fetter; Heather A. Shahzade; Jill N. Allen; Lawrence S. Blaszkowsky; Jeffrey W. Clark; Jon S. Dubois; Joseph W. Franses; Bruce J. Giantonio; Lipika Goyal; Samuel J. Klempner; Ryan D. Nipp; Eric J. Roeland; David P. Ryan; Colin D. Weekes; Jennifer Y. Wo; Theodore S. Hong; Liliana Bordeianou; Cristina R. Ferrone; Motaz Qadan; Hiroko Kunitake; David Berger; Rocco Ricciardi; James C. Cusack; Victoria M. Raymond; AmirAli Talasaz; Genevieve M. Boland; Ryan B. Corcoran
Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma
Kyrollis Attalla; Renzo G. DiNatale; Phillip M. Rappold; Christopher J. Fong; Francisco Sanchez-Vega; Andrew W. Silagy; Stanley Weng; Jonathan Coleman; Chung-Han Lee; Maria I. Carlo; Jeremy C. Durack; Stephen B. Solomon; Victor E. Reuter; Paul Russo; Timothy A. Chan; Robert J. Motzer; Nikolaus D. Schultz; Ed Reznik; Martin H. Voss; A. Ari Hakimi
Translational Cancer Mechanisms and Therapy
Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial
David Venet; Mattia Rediti; Marion Maetens; Debora Fumagalli; David N. Brown; Samira Majjaj; Roberto Salgado; Lajos Pusztai; Nadia Harbeck; Sarra El-Abed; Yingbo Wang; Cristina Saura; Henry Gomez; Vladimir Fedorovich Semiglazov; Evandro de Azambuja; Jens Huober; Paolo Nuciforo; Serena Di Cosimo; Martine Piccart; Sherene Loi; Françoise Rothé; Christos Sotiriou
Circulating Tumor DNA Analysis Detects FGFR2 Amplification and Concurrent Genomic Alterations Associated with FGFR Inhibitor Efficacy in Advanced Gastric Cancer
Tomoko Jogo; Yoshiaki Nakamura; Kohei Shitara; Hideaki Bando; Hisateru Yasui; Taito Esaki; Tetsuji Terazawa; Taroh Satoh; Eiji Shinozaki; Tomohiro Nishina; Yu Sunakawa; Yoshito Komatsu; Hiroki Hara; Eiji Oki; Nobuhisa Matsuhashi; Takashi Ohta; Takeshi Kato; Koushiro Ohtsubo; Takeshi Kawakami; Naohiro Okano; Yoshiyuki Yamamoto; Takanobu Yamada; Akihito Tsuji; Justin I. Odegaard; Hiroya Taniguchi; Toshihiko Doi; Satoshi Fujii; Takayuki Yoshino
Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1–positive Triple-negative Breast Cancer
Jodi M. Carter; Mei-Yin C. Polley; Roberto A. Leon-Ferre; Jason Sinnwell; Kevin J. Thompson; Xue Wang; Yaohua Ma; David Zahrieh; Jennifer M. Kachergus; Malvika Solanki; Judy C. Boughey; Minetta C. Liu; James N. Ingle; Krishna R. Kalari; Fergus J. Couch; E. Aubrey Thompson; Matthew P. Goetz
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial
Julien Taieb; Valérie Taly; Julie Henriques; Camille Bourreau; Laurent Mineur; Jaafar Bennouna; Jérôme Desrame; Christophe Louvet; Céline Lepere; May Mabro; Joëlle Egreteau; Olivier Bouche; Claire Mulot; Katia Hormigos; Kariman Chaba; Thibault Mazard; Aimery de Gramont; Dewi Vernerey; Thierry André; Pierre Laurent-Puig
Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL Cells
Adam J. Linley; Laura I. Karydis; Anil K. Mondru; Annalisa D'Avola; Humood Al Shmrany; Silvia Cicconi; Rebecca Griffin; Francesco Forconi; Andrew R. Pettitt; Nagesh Kalakonda; Andrew C. Rawstron; Peter Hillmen; Andrew J. Steele; David J. MacEwan; Graham Packham; Ian A. Prior; Joseph R. Slupsky
Sulindac, a Nonselective NSAID, Reduces Breast Density in Postmenopausal Women with Breast Cancer Treated with Aromatase Inhibitors
Patricia A. Thompson; Chuan Huang; Jie Yang; Betsy C. Wertheim; Denise Roe; Xiaoyue Zhang; Jie Ding; Pavani Chalasani; Christina Preece; Jessica Martinez; H.-H. Sherry Chow; Alison T. Stopeck
TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas
Edgar Gonzalez-Buendia; Junfei Zhao; Lu Wang; Subhas Mukherjee; Daniel Zhang; Víctor A. Arrieta; Eric Feldstein; J. Robert Kane; Seong Jae Kang; Catalina Lee-Chang; Aayushi Mahajan; Li Chen; Ronald Realubit; Charles Karan; Lisa Magnuson; Craig Horbinski; Stacy A. Marshall; Jann N. Sarkaria; Ahmed Mohyeldin; Ichiro Nakano; Mukesh Bansal; Charles D. James; Daniel J. Brat; Atique Ahmed; Peter Canoll; Raul Rabadan; Ali Shilatifard; Adam M. Sonabend
Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
Raquel Nunes; Tal Sella; Kai Treuner; Jennifer M. Atkinson; Jenna Wong; Yi Zhang; Pedro Exman; David Dabbs; Andrea L. Richardson; Catherine A. Schnabel; Dennis C. Sgroi; Steffi Oesterreich; Ashley Cimino-Mathews; Otto Metzger
KRAS Inhibitor Resistance in MET-Amplified KRASG12C Non–Small Cell Lung Cancer Induced By RAS- and Non–RAS-Mediated Cell Signaling Mechanisms
Shinichiro Suzuki; Kimio Yonesaka; Takeshi Teramura; Toshiyuki Takehara; Ryoji Kato; Hitomi Sakai; Koji Haratani; Junko Tanizaki; Hisato Kawakami; Hidetoshi Hayashi; Kazuko Sakai; Kazuto Nishio; Kazuhiko Nakagawa
Therapeutic Targeting of Mesothelin with Chimeric Antigen Receptor T Cells in Acute Myeloid Leukemia
Quy Le; Sommer Castro; Thao Tang; Anisha M. Loeb; Tiffany Hylkema; Cyd Nourigat McKay; LaKeisha Perkins; Shivani Srivastava; Lindsey Call; Jenny Smith; Amanda Leonti; Rhonda Ries; Laura Pardo; Michael R. Loken; Colin Correnti; Salvatore Fiorenza; Cameron J. Turtle; Stanley Riddell; Katherine Tarlock; Soheil Meshinchi
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds